{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:54:39Z","timestamp":1793501679310,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ajog.2021.06.070","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T10:35:55Z","timestamp":1624444555000},"page":"508.e1-508.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations"],"prefix":"10.1016","volume":"225","author":[{"given":"Maria J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia R.","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4578-2061","authenticated-orcid":false,"given":"Bhavana","family":"Pothuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.06.070_bib2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1067\/S0002-9378(03)00579-9","article-title":"Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades","volume":"189","author":"Barnholtz-Sloan","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.06.070_bib3","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib4","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2021.06.070_bib5","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/onc.2015.181","article-title":"Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations","volume":"35","author":"Golmard","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ajog.2021.06.070_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2021.06.070_bib7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ajog.2021.06.070_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2021.06.070_bib11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACOG Practice Bulletin no. 103: hereditary breast and ovarian cancer syndrome","volume":"113","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.06.070_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.6004\/jnccn.2016.0018","article-title":"Genetic\/familial high-risk assessment: breast and ovarian, version 2.2015","volume":"14","author":"Daly","year":"2016","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ajog.2021.06.070_bib13","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.06.070_bib14","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1200\/JCO.2003.01.088","article-title":"Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1\/BRCA2 mutation testing","volume":"21","author":"Schwartz","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib15","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/cncr.22352","article-title":"Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study","volume":"107","author":"Uyei","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2021.06.070_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.2006.07.4922","article-title":"Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1\/2 mutation carriers","volume":"25","author":"Madalinska","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib17","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ijc.23340","article-title":"International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers","volume":"122","author":"Metcalfe","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2021.06.070_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/gtmb.2008.0067","article-title":"Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers","volume":"13","author":"Beattie","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.ajog.2021.06.070_bib19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses\u2019 health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.06.070_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-0528.2011.03257.x","article-title":"Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis","volume":"119","author":"Manchanda","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2021.06.070_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/GIM.0b013e318163487d","article-title":"Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers","volume":"10","author":"Bradbury","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2021.06.070_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN Guidelines Insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.ajog.2021.06.070_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amepre.2017.10.015","article-title":"Provider discussions of genetic tests with U.S. women at risk for a BRCA mutation","volume":"54","author":"Hull","year":"2018","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajog.2021.06.070_bib24","first-page":"493","article-title":"Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: a review of the literature","volume":"67","author":"Hoskins","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2021.06.070_bib25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1200\/JCO.18.01854","article-title":"Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients","volume":"37","author":"Kurian","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40661-017-0039-8","article-title":"Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature","volume":"4","author":"Frey","year":"2017","journal-title":"Gynecol Oncol Res Pract"},{"issue":"Suppl15","key":"10.1016\/j.ajog.2021.06.070_bib27","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1200\/JCO.2020.38.15_suppl.1506","article-title":"Results from MAGENTA: a national randomized four-arm noninferiority trial evaluating pre- and post-test genetic counseling during online testing for breast and ovarian cancer genetic risk","volume":"38","author":"Swisher","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib28","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.19.02005","article-title":"Prospective feasibility trial of a novel strategy of facilitated cascade genetic testing using telephone counseling","volume":"38","author":"Frey","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2008.10.007","article-title":"Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study","volume":"112","author":"Metcalfe","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.amjsurg.2009.07.003","article-title":"Disparities in BRCA testing: when insurance coverage is not a barrier","volume":"198","author":"Olaya","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.ajog.2021.06.070_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.amepre.2010.09.027","article-title":"Awareness and utilization of BRCA1\/2 testing among U.S. primary care physicians","volume":"40","author":"Bellcross","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajog.2021.06.070_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12875-016-0483-2","article-title":"A\u00a0systematic review of interventions to provide genetics education for primary care","volume":"17","author":"Paneque","year":"2016","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.ajog.2021.06.070_bib33","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/IGC.0b013e3182849dba","article-title":"Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer","volume":"23","author":"Anderson","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2021.06.070_bib36","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE study group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/GME.0000000000000126","article-title":"Hormone therapy in oophorectomized BRCA1\/2 mutation carriers","volume":"21","author":"Marchetti","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2021.06.070_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2005.07.110","article-title":"Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers","volume":"100","author":"Kotsopoulos","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2021.06.070_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2020.01.035","volume":"157","author":"Sinno","year":"2020","journal-title":"Gynecol Oncol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821007055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821007055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:34:38Z","timestamp":1757590478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821007055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0002937821007055"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.06.070","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.06.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}